Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q4 2024 (December 31)4holders +1
2new positions
1sold out
$3.48avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($75K), SVB Wealth LLC ($47K) and GAMMA Investing LLC ($45K).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $47K |
| Exits | 1 | $723 |
All 13F filers, Q3 2024 → Q4 2024: 21,464 shares bought and 165 shares sold, net +21,299 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | No change | 21,539 | $75K |
| SVB Wealth LLC | 0.00% | New | 13,436 | $47K |
| GAMMA Investing LLC | 0.00% | Add +161.6% | 12,824 | $45K |
| First Horizon Advisors, Inc. | 0.00% | New | 107 | $371 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.